Viewing Study NCT06522139



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06522139
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: None
First Post: 2024-07-22

Brief Title: Clinical Outcome After Episealer Talus Implant in Treatment of Osteochondral Lesion of the Talus
Sponsor: None
Organization: None

Study Overview

Official Title: Clinical Outcome After Episealer Talus Implant in Treatment of Osteochondral Lesion of the Talus
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Autologous Chondrocyte Implantation ACI is an appealing technique whereby cartilage is harvested from the joint in a first operation This biopsy is processed individual cells are freed and cultivated and in a second procedure injected into the defect that has been covered by a periosteal graft A second generation includes a matrix MACI into which the cells are injectedcultivated Recently collagen membranes are used to cover the cells or cover a micro-fractured defect Good results have been reported although return to previous sports remains a challenge Long term results are lacking More important is the fact that these treatments are directed towards restoring the articular cartilage whereas the patients symptoms are generated by the bone and not the cartilage

Treatment of an OCD with a small metallic implant has been tested in recent years Results have been promising by some reports while a high revision rates was reported by others A recent 2-8 years follow-up study revealed a survival rate of 95
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None